Science Explorer Back to mapMap
Discussion
Company · Carlsbad · United States

Lineage Cell Therapeutics (United States)

Research works
115
▼ 28% vs 2018-21
Citations
3.6k
31.6 per fractional work
Top-10% rate
10.1%
all institutions 10.0%
Open access
43%
world 40%
International
22%
world 18%

Not ranked overall: Lineage Cell Therapeutics (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Lineage Cell Therapeutics (United States) work in?

In 2022-now, 53% of research at Lineage Cell Therapeutics (United States) is in Life Sciences, 30% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (44%), Medicine (27%), Immunology and Microbiology (6%). It does 2.7× the world's share of Life Sciences.

Life Sciences: 15 fractional works · 53.1% of its workBiochemistry, Genetics and Molecular Biology: 12 fractional works · 44.3% of its workMolecular Biology: 9 fractional works · 31.9% of its workGenetics: 2 fractional works · 6.3% of its workCancer Research: 1 fractional works · 3.7% of its workEndocrinology: 0 fractional works · 1.2% of its workBiophysics: 0 fractional works · 0.4% of its workBiotechnology: 0 fractional works · 0.3% of its workCell Biology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 2 fractional works · 5.7% of its workImmunology: 1 fractional works · 3.9% of its workParasitology: 0 fractional works · 1.2% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.6% of its workAgricultural and Biological Sciences: 0 fractional works · 1.2% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.6% of its workPlant Science: 0 fractional works · 0.6% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.2% of its workPharmaceutical Science: 0 fractional works · 0.6% of its workPharmacology: 0 fractional works · 0.6% of its workNeuroscience: 0 fractional works · 0.7% of its workCognitive Neuroscience: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.3% of its workHealth Sciences: 8 fractional works · 29.8% of its workMedicine: 8 fractional works · 27.0% of its workRadiology, Nuclear Medicine and Imaging: 2 fractional works · 8.7% of its workOncology: 2 fractional works · 7.2% of its workHematology: 1 fractional works · 2.5% of its workSurgery: 0 fractional works · 1.7% of its workPathology and Forensic Medicine: 0 fractional works · 1.5% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.4% of its workPharmacology: 0 fractional works · 1.2% of its workEpidemiology: 0 fractional works · 0.6% of its workPhysiology: 0 fractional works · 0.5% of its workGenetics: 0 fractional works · 0.5% of its workGastroenterology: 0 fractional works · 0.4% of its workNeurology: 0 fractional works · 0.4% of its workOtorhinolaryngology: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 1.6% of its workComplementary and Manual Therapy: 0 fractional works · 1.2% of its workSpeech and Hearing: 0 fractional works · 0.4% of its workDentistry: 0 fractional works · 1.2% of its workOrthodontics: 0 fractional works · 1.2% of its workSocial Sciences: 3 fractional works · 10.6% of its workArts and Humanities: 1 fractional works · 3.1% of its workArcheology: 1 fractional works · 1.9% of its workLiterature and Literary Theory: 0 fractional works · 1.2% of its workSmaller subfields together: 0 fractional works · 0.0% of its workPsychology: 1 fractional works · 3.0% of its workDevelopmental and Educational Psychology: 1 fractional works · 3.0% of its workSocial Sciences: 1 fractional works · 3.0% of its workEducation: 1 fractional works · 3.0% of its workBusiness, Management and Accounting: 0 fractional works · 1.0% of its workStrategy and Management: 0 fractional works · 0.5% of its workManagement Information Systems: 0 fractional works · 0.3% of its workOrganizational Behavior and Human Resource Management: 0 fractional works · 0.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.5% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workGeneral Economics, Econometrics and Finance: 0 fractional works · 0.3% of its workPhysical Sciences: 2 fractional works · 6.5% of its workEngineering: 1 fractional works · 2.9% of its workElectrical and Electronic Engineering: 0 fractional works · 1.2% of its workBiomedical Engineering: 0 fractional works · 1.1% of its workCivil and Structural Engineering: 0 fractional works · 0.6% of its workEnvironmental Science: 1 fractional works · 2.1% of its workWater Science and Technology: 0 fractional works · 0.9% of its workEnvironmental Engineering: 0 fractional works · 0.4% of its workGlobal and Planetary Change: 0 fractional works · 0.4% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 0.4% of its workEarth and Planetary Sciences: 0 fractional works · 0.9% of its workEarth-Surface Processes: 0 fractional works · 0.9% of its workChemistry: 0 fractional works · 0.6% of its workOrganic Chemistry: 0 fractional works · 0.6% of its workALL ITS WORKLineage CellTherapeutics…28fractional works, 2022-now
Life Sciences53%Physical Sciences7%Health Sciences30%Social Sciences11%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 17 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1244.3%
    2. Immunology and Microbiology25.7%
    3. Agricultural and Biological Sciences01.2%
    4. Pharmacology, Toxicology and Pharmaceutics01.2%
    5. Neuroscience00.7%
    1. Medicine827.0%
    2. Health Professions01.6%
    3. Dentistry01.2%
    1. Arts and Humanities13.1%
    2. Psychology13.0%
    3. Social Sciences13.0%
    4. Business, Management and Accounting01.0%
    5. Economics, Econometrics and Finance00.5%
    1. Engineering12.9%
    2. Environmental Science12.1%
    3. Earth and Planetary Sciences00.9%
    4. Chemistry00.6%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.25× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 8.29× its world share, 12 worksBiochemistry, Geneti…Immunology and Microbiology: 5.68× its world share, 2 worksImmunology and Micro…Neuroscience: 0.43× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 3.41× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.38× its world share, 0 worksChemistryEarth and Planetary Sciences: 0.57× its world share, 0 worksEarth and Planetary …Engineering: 0.20× its world share, 1 worksEngineeringEnvironmental Science: 0.42× its world share, 1 worksEnvironmental ScienceDentistry: 2.48× its world share, 0 worksDentistryHealth Professions: 0.61× its world share, 0 worksHealth ProfessionsMedicine: 1.41× its world share, 8 worksMedicineArts and Humanities: 1.08× its world share, 1 worksArts and HumanitiesBusiness, Management and Accounting: 0.30× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.22× its world share, 0 worksEconomics, Econometr…Psychology: 0.99× its world share, 1 worksPsychologySocial Sciences: 0.24× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 8.3×. Every wedge is a field page.

All 17 fields, with their numbers
  1. Biochemistry, Genetics and Molecular Biology8.29×12 works
  2. Immunology and Microbiology5.68×2 works
  3. Pharmacology, Toxicology and Pharmaceutics3.41×0 works
  4. Dentistry2.48×0 works
  5. Medicine1.41×8 works
  6. Arts and Humanities1.08×1 works
  7. Psychology0.99×1 works
  8. Health Professions0.61×0 works
  9. Earth and Planetary Sciences0.57×0 works
  10. Neuroscience0.43×0 works
  11. Environmental Science0.42×1 works
  12. Chemistry0.38×0 works
  13. Business, Management and Accounting0.30×0 works
  14. Agricultural and Biological Sciences0.25×0 works
  15. Social Sciences0.24×1 works
  16. Economics, Econometrics and Finance0.22×0 works
  17. Engineering0.20×1 works

Who are the top researchers at Lineage Cell Therapeutics (United States)?

Ranked on the quality score, Thomas I. Zarembinski, Gascón y Guimbao, Domingo, 1845-1908 and Edward Robert Wassman lead among researchers whose main affiliation is Lineage Cell Therapeutics (United States).

  1. 1 Thomas I. Zarembinski United States · #504,079 worldwide 2.2k citations · 36 works
  2. 2 Gascón y Guimbao, Domingo, 1845-1908 United States · #1,804,318 worldwide 0 citations · 139 works
  3. 3 Edward Robert Wassman United States · #1,819,236 worldwide 966 citations · 32 works
  4. 4 François Binette United States · #2,352,135 worldwide 2.7k citations · 37 works
  5. 5 Rena J. Vanzo United States · #2,464,832 worldwide 1.2k citations · 40 works
  6. 6 Igor O. Nasonkin United States · #2,802,676 worldwide 2k citations · 69 works
  7. 7 Megan M. Martin United States · #4,762,221 worldwide 625 citations · 60 works
  8. 8 Hal Sternberg United States · #5,038,336 worldwide 1.1k citations · 68 works
  9. 9 Ratnesh Kumar Singh United States · #5,089,353 worldwide 575 citations · 33 works
All ranked researchers at Lineage Cell Therapeutics (United States)

What are the most cited papers from Lineage Cell Therapeutics (United States)?

The most cited paper from Lineage Cell Therapeutics (United States) is "Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)" (Erin Rooney Riggs, Erica Andersen, Athena M. Cherry et al., 2019), with 1,854 citations. Next come "A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes" (1,092) and "Rapid vascular regrowth in tumors after reversal of VEGF inhibition" (808).

Most cited papers
#PaperReleasedCitations
1 Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) Erin Rooney Riggs, Erica Andersen, Athena M. Cherry et al. · Genetics in Medicine Open access 5 Nov 2019 1,854
2 A Large-Scale Genetic Association Study Confirms IL12B and Leads to the Identification of IL23R as Psoriasis-Risk Genes Michele Cargill, Steven J. Schrodi, Monica Chang et al. · The American Journal of Human Genetics Open access 19 Jan 2007 1,092
3 Rapid vascular regrowth in tumors after reversal of VEGF inhibition Michael R. Mancuso, Rachel B. Davis, Scott Michael Norberg et al. · Journal of Clinical Investigation Open access 2 Oct 2006 808
4 Oncolytic DNX-2401 virotherapy plus pembrolizumab in recurrent glioblastoma: a phase 1/2 trial Farshad Nassiri et al. · Nature Medicine Open access 15 May 2023 296
5 GRIN2B encephalopathy: novel findings on phenotype, variant clustering, functional consequences and treatment aspects Konrad Platzer et al. · Journal of Medical Genetics Open access 4 Apr 2017 261
All 59 most cited papers, with filters and sorting

Which keywords describe research at Lineage Cell Therapeutics (United States)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Gene Expression, Quantitative, Cancer, Data Analysis, Normalization, Glycosylation, Cancer Immunotherapy and Fc Receptors.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Gene Expression2▲ 14×5 topics
  2. Quantitative2▲ 95×2 topics
  3. Cancer2▲ 5.7×12 topics
  4. Epidemiology2▲ 1.54×8 topics
  5. Data Analysis2▲ 20×2 topics
  6. Normalization2▲ 107×2 topics
  7. Glycosylation1▲ 45×2 topics
  8. Immunotherapy1▲ 6.8×5 topics
  9. Cancer Immunotherapy1▲ 32×2 topics
  10. Fc Receptors1▲ 88×1 topic
  11. Real-Time PCR1▲ 188×1 topic
  12. Reference Genes1▲ 188×1 topic
  13. Therapeutic Antibodies1▲ 69×1 topic
  14. High-Throughput Analysis1▲ 117×1 topic
  15. Imaging1▲ 17×2 topics
  16. Protein Microarrays1▲ 239×1 topic
  17. Tumor Regression1▲ 36×2 topics
  18. Brain Development1▲ 21×2 topics
  19. CAR T Cells1▲ 50×1 topic
  20. Chimeric Antigen Receptor1▲ 50×1 topic
  21. Fragile X Syndrome1▲ 132×1 topic
  22. Genetic Mutations1▲ 8.6×2 topics
  23. PET/CT1▲ 66×1 topic
  24. Rett Syndrome1▲ 132×1 topic
  25. Targeted Therapy1▲ 16×3 topics
  26. tumor1▲ 66×1 topic

Which research topics does Lineage Cell Therapeutics (United States) publish most on?

By volume in 2022-now: Monoclonal and Polyclonal Antibodies Research, Molecular Biology Techniques and Applications, Advanced Biosensing Techniques and Applications and Genetics and Neurodevelopmental Disorders.

  1. 1 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  2. 2 Molecular Biology Techniques and Applications Molecular Biology 1 works
  3. 3 Advanced Biosensing Techniques and Applications Molecular Biology 1 works
  4. 4 Genetics and Neurodevelopmental Disorders Genetics 1 works
  5. 5 Medical Imaging Techniques and Applications Radiology, Nuclear Medicine and Imaging 1 works
  6. 6 CAR-T cell therapy research Oncology 1 works
  7. 7 Cancer Genomics and Diagnostics Cancer Research 1 works
  8. 8 Single-cell and spatial transcriptomics Molecular Biology 1 works
  9. 9 Reading and Literacy Development Developmental and Educational Psychology 1 works
  10. 10 Advanced biosensing and bioanalysis techniques Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available42.6%not open57.4%

World: 40% of research is openly available.

with international co-authors22.1%domestic only77.9%

World: 18% is written across borders.

How has Lineage Cell Therapeutics (United States)'s research output changed?

Output in 2022-2025 was 28% lower than in 2018-2021.

still counting200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Lineage Cell Therapeutics (United States) as a percentage of every work published that year, 0.00022% in 2024.

still counting0.00010%0.00020%0.00030%Lineage Cell Therapeutics (United States)0.000058% in 202519801990200020102020

Fractional works of Lineage Cell Therapeutics (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Carlsbad

All research institutions in Carlsbad

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Lineage Cell Therapeutics (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.